Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast (EMBRACE) for plaque psoriasis with impaired QoL
NCT03774875Phase 4Completed
- Sponsor
- Amgen
- Start
- Mar 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 4 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Mar 2019; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03774875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774875.